Risk and predictors of dyssynchrony cardiomyopathy in left bundle branch block with preserved left ventricular

Sunita Sharma1, Harsh V Barot1, Andrew D Schwartzman1

  • 1From the Division of Cardiovascular Medicine, Lahey Hospital and Medical Center, Burlington, Massachusetts, USA.

Clinical Cardiology
|September 17, 2020
PubMed

Insights

Seventeen percent of patients with left bundle branch block (LBBB) and preserved ejection fraction develop cardiomyopathy. Serial assessment of left ventricular function is recommended for this high-risk group.

Area of Science:

  • Cardiology
  • Cardiac Electrophysiology
  • Cardiomyopathy Research

Background:

  • Left bundle branch block (LBBB) can lead to left ventricular (LV) dyssynchrony and progressive systolic dysfunction.
  • Initial evaluation of LBBB typically includes screening for structural heart disease and coronary artery disease (CAD).
  • The long-term risk of cardiomyopathy in LBBB patients with preserved ejection fraction (EF) is not well-established.

Purpose of the Study:

  • To determine the incidence of developing LV systolic dysfunction in LBBB patients with initially preserved LVEF.
  • To identify predictors for the development of cardiomyopathy in this patient cohort.
  • To establish the need for serial cardiac imaging in LBBB patients with preserved LVEF.

Main Methods:

  • Retrospective review of 1000 LBBB patients' records.
  • Inclusion criteria: preserved LVEF (≥45%) and absence of significant CAD or other cardiomyopathy causes.
  • Follow-up imaging and clinical data were collected to assess for subsequent LV systolic dysfunction (LVEF ≤40%).

Main Results:

  • 17% (37 of 216) of patients developed reduced LVEF (≤40%) over a mean follow-up of 55 months.
  • Baseline LVEF ≤60% and LV end-systolic diameter ≥2.9 cm were associated with increased risk.
  • A preserved LVEF >60% and LV end-systolic diameter <2.9 cm had a 98% negative predictive value.

Conclusions:

  • A significant proportion of LBBB patients with preserved LVEF develop dyssynchrony cardiomyopathy.
  • Serial assessment of LV systolic function is warranted in this high-risk population.
  • Specific baseline parameters can help identify patients needing closer monitoring.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
235
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
274
Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
349
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.0K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
347
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
304